- Report
- November 2024
- 150 Pages
Global
From €3453EUR$3,850USD£3,044GBP
€4350EUR$4,850USD£3,835GBP
- Report
- November 2024
- 150 Pages
Global
From €3453EUR$3,850USD£3,044GBP
€4350EUR$4,850USD£3,835GBP
- Report
- May 2025
- 125 Pages
Global
From €4261EUR$4,750USD£3,756GBP
- Report
- May 2025
- 110 Pages
Global
From €4261EUR$4,750USD£3,756GBP
- Report
- March 2025
- 181 Pages
Global
From €4036EUR$4,500USD£3,558GBP
- Report
- June 2025
- 400 Pages
Global
From €4439EUR$4,949USD£3,914GBP
- Report
- June 2025
- 400 Pages
Global
From €4439EUR$4,949USD£3,914GBP
- Report
- August 2025
- 161 Pages
Global
From €3228EUR$3,599USD£2,846GBP
- Report
- August 2025
- 153 Pages
Global
From €3228EUR$3,599USD£2,846GBP
- Report
- August 2025
- 155 Pages
Global
From €3228EUR$3,599USD£2,846GBP
- Report
- August 2025
- 173 Pages
Global
From €3228EUR$3,599USD£2,846GBP
- Report
- July 2025
- 350 Pages
Global
From €4439EUR$4,949USD£3,914GBP
- Report
- July 2025
- 350 Pages
Global
From €4439EUR$4,949USD£3,914GBP
- Report
- July 2025
- 350 Pages
Global
From €4439EUR$4,949USD£3,914GBP
- Report
- July 2025
- 350 Pages
Global
From €4439EUR$4,949USD£3,914GBP
- Report
- July 2025
- 350 Pages
Global
From €4439EUR$4,949USD£3,914GBP
- Report
- July 2025
- 350 Pages
Global
From €4439EUR$4,949USD£3,914GBP
- Report
- July 2025
- 350 Pages
Global
From €4439EUR$4,949USD£3,914GBP
- Report
- July 2025
- 350 Pages
Global
From €4439EUR$4,949USD£3,914GBP
- Report
- July 2025
- 350 Pages
Global
From €4439EUR$4,949USD£3,914GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more